Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-24 @ 2:13 AM
Study NCT ID:
NCT03016468
Status:
WITHDRAWN
Last Update Posted:
2017-04-11
First Post:
2017-01-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
Sponsor:
United Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-09
Completion Date Type:
ESTIMATED
First Submit Date:
2017-01-06
First Submit QC Date:
None
Study First Post Date:
2017-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-07
Last Update Post Date:
2017-04-11
Last Update Post Date Type:
ACTUAL